» Articles » PMID: 21805180

Liposomal Systems As Drug Delivery Vehicles for Dermal and Transdermal Applications

Overview
Specialty Dermatology
Date 2011 Aug 2
PMID 21805180
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Enhancement strategies are necessary to improve the dermal/transdermal bioavailability of drugs applied to the skin due to its amazing barrier, the stratum corneum. Strategies to overcome this barrier, thus improving drug release to the skin include the use of penetration enhancers, specific delivery systems, supersaturated solutions and physical methods (iontophoresis, electroporation and ultrasound). Delivery of active agents to the skin by liposomal carriers has improved topical therapy in the field of dermatology. The interest in these carriers is based on their potential to enclose various types of biological materials and to deliver them to diverse cell types. Particularly, in recent years liposomes have been shown to be a promising drug-delivery system to the skin. Their use may produce several-fold higher drug concentrations in the epidermis and dermis and lower systemic concentrations when compared to conventional dosage forms. On the other hand, special characteristic vesicles like ethosomes, transfersomes and niosomes may be potential transdermal delivery systems for ionic molecules and polypeptides.

Citing Articles

Nanoparticle-Encapsulated Plant Polyphenols and Flavonoids as an Enhanced Delivery System for Anti-Acne Therapy.

Puspadewi R, Milanda T, Muhaimin M, Chaerunisaa A Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40006023 PMC: 11858878. DOI: 10.3390/ph18020209.


Exploring the Therapeutic Potential of Vesicular Nanocarrier Systems for Elimination of Skin Cancer.

Kumar L, Rana R, Komal K, Aggarwal V, Kumar S, Choudhary N Curr Med Chem. 2025; 32(2):258-285.

PMID: 39962707 DOI: 10.2174/0109298673297695240328074724.


The Potential Application of Nanocarriers in Delivering Topical Antioxidants.

Zazuli Z, Hartati R, Rowa C, Asyarie S, Satrialdi Pharmaceuticals (Basel). 2025; 18(1).

PMID: 39861119 PMC: 11769529. DOI: 10.3390/ph18010056.


Cathelicidins: Opportunities and Challenges in Skin Therapeutics and Clinical Translation.

Dzurova L, Holaskova E, Pospisilova H, Schneider Rauber G, Frebortova J Antibiotics (Basel). 2025; 14(1).

PMID: 39858288 PMC: 11762488. DOI: 10.3390/antibiotics14010001.


Nanotechnology-Driven Delivery of Caffeine Using Ultradeformable Liposomes-Coated Hollow Mesoporous Silica Nanoparticles for Enhanced Follicular Delivery and Treatment of Androgenetic Alopecia.

Thepphankulngarm N, Manmuan S, Hirun N, Kraisit P Int J Mol Sci. 2024; 25(22).

PMID: 39596238 PMC: 11595114. DOI: 10.3390/ijms252212170.